 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Autoimmune limbic encephalitis combined with leptomeningeal metastases of non-small cell lung cancer: treatment response to osimertinib, immunoglobulin, rituximab, and tocilizumab |
| Seolah Lee, Seon-Jae Ahn, Han Sang Lee, Kon Chu |
|
Encephalitis. 2023;3(1):34-38. Published online January 6, 2023 DOI: https://doi.org/10.47936/encephalitis.2022.00122 |
|
Autoimmune limbic encephalitis combined with leptomeningeal metastases of non-small cell lung cancer: treatment response to osimertinib, immunoglobulin, rituximab, and tocilizumab encephalitis. 2023;3(1):34-38  Durable response to osimertinib in EGFR mutated T790M wildtype non-small cell lung cancer with leptomeningeal metastases: A case report Lung Cancer. 2017;114:68-69 Leptomeningeal metastases in non-small cell lung cancer: Diagnosis and treatment Lung Cancer. 2022;174:1-13 <p>Treatment Response To Osimertinib In <em>EGFR</em>-Mutated Leptomeningeal Metastases From Non-Small Cell Lung Cancer: A Case Series</p> OncoTargets and Therapy. 2019;Volume 12:7785-7790 Treatment and prognostic analysis of patients with leptomeningeal metastases from non-small cell lung cancer Thoracic Cancer. 2015;6(4):407-412 Osimertinib Combined with Systemic Chemotherapy for EGFR Mutant, T790M-Negative, Non–Small Cell Lung Cancer Patients Who Develop Leptomeningeal Metastases with Extracranial Progression to Prior EGFR TKI Cancer Research and Treatment. 2023;55(1):344-349 Simultaneous leptomeningeal and intramedullary spinal metastases in small cell lung carcinoma Lung Cancer. 1986;2(4):267 Successful Remedy With Osimertinib in a Patient of Thr790Met-positive Non-small Cell Lung Cancer With Leptomeningeal Carcinomatosis and Resistant to Gefitinib . 2021; Standard-dose osimertinib for refractory leptomeningeal metastases in T790M-positive EGFR-mutant non-small cell lung cancer British Journal of Cancer. 2017;118(1):32-37 Successful treatment of solitary extracranial metastases from non-small cell lung cancer Lung Cancer. 1996;15(3):390 |
